LUKE EVNIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LUKE EVNIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LUKE EVNIN. LUKE EVNIN is in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and in Syndax Pharmaceuticals Inc ($SNDX) and Director in Syndax Pharmaceuticals Inc ($SNDX) and in Radius Health, Inc. ($RDUS) and Director in Harpoon Therapeutics, Inc. ($HARP) and Director in Werewolf Therapeutics, Inc. ($HOWL) and Chief Executive Officer in TURMERIC ACQUISITION CORP. ($TMPM).
Latest Insider Trading Transactions of LUKE EVNIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HARP, RDUS, RIGL, SNDX, TMPMU, HOWL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2021 | HOWL | Werewolf Therapeut ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 7,939,970 | 0 | 0 | |
May 06 2021 | HOWL | Werewolf Therapeut ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 23,892,677 | 0 | 0 | |
May 06 2021 | HOWL | Werewolf Therapeut ... | EVNIN LUKE | Director | Option Exercise | P | 0.00 | 7,939,970 | 0 | 7,939,970 | |
May 06 2021 | HOWL | Werewolf Therapeut ... | EVNIN LUKE | Director | Buy | P | 16.00 | 150,799 | 2,412,784 | 4,284,172 | 4.1 M to 4.3 M (+3.65 %) |
May 06 2021 | HOWL | Werewolf Therapeut ... | EVNIN LUKE | Director | Buy | C | 0.00 | 915,892 | 0 | 4,133,373 | 3.2 M to 4.1 M (+28.47 %) |
May 06 2021 | HOWL | Werewolf Therapeut ... | EVNIN LUKE | Director | Buy | C | 0.00 | 2,756,073 | 0 | 3,217,481 | 461.4 K to 3.2 M (+597.32 %) |
May 03 2021 | HOWL | Werewolf Therapeut ... | EVNIN LUKE | Director | Option Exercise | A | 16.00 | 23,200 | 371,200 | 23,200 | |
Apr 30 2021 | TMPMU | TURMERIC ACQUISITI ... | EVNIN LUKE | Chief Executive Off ... | Option Exercise | J | 0.00 | 17,500 | 0 | 2,298,750 | |
Oct 20 2020 | TMPM | TURMERIC ACQUISITI ... | EVNIN LUKE | Chief Executive Off ... | Buy | J | 10.00 | 415,500 | 4,155,000 | 415,500 | 0 to 415.5 K |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | EVNIN LUKE | Director | Option Exercise | A | 20.59 | 3,587 | 73,856 | 3,587 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | EVNIN LUKE | Director | Option Exercise | A | 20.59 | 10,167 | 209,339 | 10,167 | |
Jun 05 2019 | HARP | Harpoon Therapeuti ... | EVNIN LUKE | Director | Option Exercise | A | 11.84 | 10,167 | 120,377 | 10,167 | |
May 25 2018 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Option Exercise | A | 8.93 | 14,000 | 125,020 | 14,000 | ||
Feb 12 2018 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Option Exercise | A | 9.63 | 10,000 | 96,300 | 10,000 | ||
May 19 2017 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Option Exercise | A | 13.58 | 5,000 | 67,900 | 5,000 | ||
May 19 2017 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Option Exercise | A | 13.58 | 10,000 | 135,800 | 10,000 | ||
Nov 02 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Option Exercise | A | 11.81 | 8,000 | 94,480 | 8,000 | ||
Sep 29 2016 | RDUS | Radius Health, Inc ... | EVNIN LUKE | Sell | J | 0.00 | 1,943,751 | 0 | 3,887,502 | 5.8 M to 3.9 M (-33.33 %) | |
Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 312,085 | 0 | 0 | |
Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 718,396 | 0 | 0 | |
Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 1,138,210 | 0 | 0 | |
Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Buy | C | 0.00 | 312,085 | 0 | 2,168,691 | 1.9 M to 2.2 M (+16.81 %) |
Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Buy | C | 0.00 | 718,396 | 0 | 1,856,606 | 1.1 M to 1.9 M (+63.12 %) |
Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Buy | C | 0.00 | 1,138,210 | 0 | 1,138,210 | 0 to 1.1 M |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | Buy | J | 0.00 | 475,026 | 0 | 475,026 | 0 to 475 K | |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | Sell | J | 0.00 | 1,687,072 | 0 | 0 | 1.7 M to 0 (-100.00 %) | |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 21.13 | 24,500 | 517,719 | 1,687,072 | 1.7 M to 1.7 M (-1.43 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 20.60 | 60,527 | 1,246,626 | 1,711,572 | 1.8 M to 1.7 M (-3.42 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 19.77 | 826 | 16,330 | 1,772,099 | 1.8 M to 1.8 M (-0.05 %) |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 21.84 | 27,499 | 600,619 | 1,772,925 | 1.8 M to 1.8 M (-1.53 %) |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 21.77 | 5,000 | 108,847 | 1,800,424 | 1.8 M to 1.8 M (-0.28 %) |
Aug 18 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 21.80 | 5,400 | 117,720 | 1,805,424 | 1.8 M to 1.8 M (-0.30 %) |
Aug 18 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 22.44 | 13,599 | 305,216 | 1,810,824 | 1.8 M to 1.8 M (-0.75 %) |
Aug 17 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 22.30 | 10,000 | 223,000 | 1,824,423 | 1.8 M to 1.8 M (-0.55 %) |
Jul 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 14.88 | 7,847 | 116,786 | 1,833,597 | 1.8 M to 1.8 M (-0.43 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Buy | J | 0.00 | 16,203 | 0 | 1,849,800 | 1.8 M to 1.8 M (+0.88 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | J | 0.00 | 1,499,989 | 0 | 1,833,597 | 3.3 M to 1.8 M (-45.00 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 15.83 | 2,877 | 45,545 | 3,333,586 | 3.3 M to 3.3 M (-0.09 %) |
Jun 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 15.80 | 54,500 | 861,182 | 3,336,463 | 3.4 M to 3.3 M (-1.61 %) |
Jun 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 15.54 | 69,807 | 1,084,850 | 3,390,963 | 3.5 M to 3.4 M (-2.02 %) |
Jun 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 15.50 | 388 | 6,014 | 3,460,770 | 3.5 M to 3.5 M (-0.01 %) |
Jun 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 15.51 | 29,805 | 462,153 | 3,461,158 | 3.5 M to 3.5 M (-0.85 %) |
Jun 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 18.00 | 2,030 | 36,540 | 3,490,963 | 3.5 M to 3.5 M (-0.06 %) |
Jun 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 17.95 | 10,000 | 179,500 | 3,492,993 | 3.5 M to 3.5 M (-0.29 %) |
Jun 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 18.00 | 3,950 | 71,100 | 3,502,993 | 3.5 M to 3.5 M (-0.11 %) |
May 27 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 17.85 | 20,154 | 359,672 | 3,506,943 | 3.5 M to 3.5 M (-0.57 %) |
May 27 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 17.80 | 5,861 | 104,326 | 3,527,097 | 3.5 M to 3.5 M (-0.17 %) |
May 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 17.35 | 3,300 | 57,255 | 3,532,958 | 3.5 M to 3.5 M (-0.09 %) |
May 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 17.25 | 139,313 | 2,402,857 | 3,536,258 | 3.7 M to 3.5 M (-3.79 %) |
Apr 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 20.78 | 133,698 | 2,778,605 | 3,675,571 | 3.8 M to 3.7 M (-3.51 %) |
Apr 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 20.30 | 25,000 | 507,500 | 3,809,269 | 3.8 M to 3.8 M (-0.65 %) |
Apr 13 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 19.80 | 400 | 7,920 | 3,834,269 | 3.8 M to 3.8 M (-0.01 %) |
Apr 13 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 19.93 | 315,902 | 6,295,927 | 3,834,669 | 4.2 M to 3.8 M (-7.61 %) |
Mar 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 20.00 | 17,334 | 346,680 | 4,150,571 | 4.2 M to 4.2 M (-0.42 %) |
Mar 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 20.00 | 17,334 | 346,680 | 4,150,571 | 4.2 M to 4.2 M (-0.42 %) |
Page: 1